Skip to main content

Table 3 Characteristics of patients with persistent disease according to the 2015 ATA risk-stratification system

From: Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome

  LR
(n = 22)
IR
(n = 66)
HR
(n = 19)
p
PD tumor burden
 Very small-volume 13 (59%) 11 (17%) 0  
 Small-volume 5 (23%) 18 (27%) 2 (11%) <.0001
 Large-volume 4 (18%) 37 (56%) 17 (89%)